Clopidogrel: The outcome in Belgium

In Belgium, Sanofi attacked the distributor of the combo-boxes on the basis of indirect patent infringement, asserting that the combo-box was an essential means of offering for use clopidogrel and aspirin as a medicinal product for the treatment of platelet aggregation.